Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T20:43:04.449Z.
Calculation as of: 2026-10-06T20:43:04.449Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0bb308cc02f92ae7022b98057b1ab9be430f0ff9c4f6ee28c48a1717489dc78b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$469.12M
Price/OCF Ratio
N/A
TTM Avg
112.22
3Y Avg
112.22
5Y Avg
112.22
Market Cap
$471.57M
Price/OCF Ratio
195.10
TTM Avg
142.73
3Y Avg
100.92
5Y Avg
100.92
Market Cap
$472.23M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
Price/OCF Ratio
N/A
TTM Avg
25.67
3Y Avg
25.67
5Y Avg
25.67
Market Cap
$483.54M
Price/OCF Ratio
11.75
TTM Avg
8.06
3Y Avg
6.53
5Y Avg
6.99
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $465.75M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $467.90M | 12.99 | 15.89 | 21.03 | 20.03 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | N/A | 112.22 | 112.22 | 112.22 |
| Cerus Corporation (CERS)vs › | $471.57M | 195.10 | 142.73 | 100.92 | 100.92 |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | 5.46 | 5.49 | 10.64 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | 25.67 | 25.67 | 25.67 |
| NRC Health (NRC)vs › | $452.54M | 15.34 | 15.15 | 16.14 | 19.77 |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 11.75 | 8.06 | 6.53 | 6.99 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | N/A | 15.33 | 15.33 | 15.33 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
